Summary
Join us for an in-depth look at Phoenix 8.9, the latest release of the industry-standard software for PK/PD analysis. This release focuses on helping teams standardize their analyses and repeat them with confidence. It brings major improvements to PK Submit, NCA, LinMix and Bioequivalence, and Phoenix NLME, with an emphasis on reusable configurations, less rework when data changes, and more complete submission outputs.
Whether you are a PK scientist, a pharmacometrician, or a PK group manager, this session will show how Phoenix 8.9 helps you set your analysis standards once, rerun analyses on updated data without starting over, and deliver regulatory-ready CDISC outputs with less manual effort.
What you will learn:
- How Configurations (master configuration files) in PK Submit let you define, lock, and apply your team’s analysis standards for each study type in one step.
- How analysts can reapply previous settings in PK Submit when new source data arrives, so you don’t have to set up the analysis again by hand.
- How new CDISC outputs, including DM, EX, and ADSL datasets and optional edit capabilities for PC and PP worksheets, round out your submission package when using PK Submit.
- How the new Rsq acceptance rule, geometric means for sparse sampling, and more accurate LinMix and Bioequivalence confidence intervals give you more control and precision in your analyses.
- How left joins, Model Comparer updates in NLME, and a new read-only license improve everyday workflows across Phoenix.
Register now
Michael Clifton
Manager, Product Management, Integral Team at CertaraMichael Clifton is a Product Manager at Certara in the Data Sciences Software portfolio and currently provides ownership and subject matter expertise to the PK Submit product. Michael has 20+ years of experience working in the pharmaceutical industry primarily focused on pharmacokinetics and senior scientist leadership. He is a former PK research scientist in the CRO space, focusing on both clinical and nonclinical studies.
Register now
